0001127602-17-022382.txt : 20170629 0001127602-17-022382.hdr.sgml : 20170629 20170629171030 ACCESSION NUMBER: 0001127602-17-022382 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170628 FILED AS OF DATE: 20170629 DATE AS OF CHANGE: 20170629 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Bioverativ Inc. CENTRAL INDEX KEY: 0001681689 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 813461310 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 225 2ND AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 781-663-4400 MAIL ADDRESS: STREET 1: 225 2ND AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Duvall Diantha CENTRAL INDEX KEY: 0001696784 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37859 FILM NUMBER: 17939357 MAIL ADDRESS: STREET 1: BIOVERATIV INC. STREET 2: 225 SECOND AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2017-06-28 0001681689 Bioverativ Inc. BIVV 0001696784 Duvall Diantha 225 2ND AVENUE WALTHAM MA 02451 1 Chief Accounting Officer Common Stock 2017-06-28 4 S 0 818 60.47 D 2128 D Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934. /s/ Matthew S. Gilman, attorney-in-fact for Diantha Duvall 2017-06-29